Organization (Academic)
YESHIVA UNIVERSITY
ClinicalTrials.gov lists YESHIVA UNIVERSITY as lead sponsor of 422 trials, counting the companies grouped under it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. Companies grouped under this one are not included. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 1 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Logo Unknown author Unknown author, via Wikimedia Commons, Public domain. Shown to identify the organization; it may be a registered trademark.
This page covers YESHIVA UNIVERSITY and 1 company grouped under it: 422 lead-sponsored trials (8 its own, 414 in the grouped companies) and 3 legal-entity registrations (2 its own, 1 in the grouped companies).
Companies grouped under this page (1)
| Company | Lead trials | Legal entities |
|---|---|---|
| Montefiore Medical Center | 414 | 1 |
Disease areas (340)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Pain | 74 |
| HIV Infections | 23 |
| Substance-Related Disorders | 23 |
| Asthma | 19 |
| Migraine Disorders | 17 |
Showing 5 of 340 disease areas.
Trials by start year as sponsor or collaborator (9)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 1 |
| 2025 | 2 |
| 2024 | 5 |
| 2023 | 3 |
| 2022 | 1 |
| 2020 | 1 |
| 2017 | 1 |
| 2016 | 1 |
| 2007 | 1 |
Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 2 of 4 hit target (n=4) | 1 of 4 on time (n=4) |
Journals published in (982)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| The New England journal of medicine | 69 |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 46 |
| JAMA | 44 |
| Obstetrics and gynecology | 34 |
| Pediatrics | 33 |
Showing 5 of 982 journals.
US granted patents (1)
Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.
| US patents granted | Granted in the last 5 years | Most recent grant |
|---|---|---|
| 62 | 11 | 2025-10-07 |
Financing and grant events (15)
Shown in this order: most recent first.
| Date | Round type | Amount (USD) | Source |
|---|---|---|---|
| 2026-05-19 | NIH grant | 652,465 | Reporter |
| 2025-08-13 | NIH grant | 845,525 | Reporter |
| 2025-03-14 | NIH grant | 154,002 | Reporter |
| 2024-09-19 | NIH grant | 144,510 | Reporter |
| 2024-07-29 | NIH grant | 652,084 | Reporter |
Showing 5 of 15 events.
Organization relationships (95)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Montefiore Health System | Co sponsors trial with | 12 |
| Government of the United States of America | Co sponsors trial with | 8 |
| The Emmes Company, LLC | Co sponsors trial with | 4 |
| AIDS Malignancy Consortium | Co sponsors trial with | 3 |
| M.D. Anderson Cancer Center | Co sponsors trial with | 3 |
Showing 5 of 95 relationships.
Latest dated events (604)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2027-07 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-12 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-11 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-10-03 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-10 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 604 events.
CLIA clinical laboratory certificates (1)
| Lab | Certificate | Status |
|---|---|---|
| YESHIVA UNIVERSITY | Certificate of waiver | Terminated |
Biomarker capability evidence (2)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| OSR1 | Trial sponsor | Named in trial inclusion criteria |
| OSR1 | Trial sponsor | Mentioned in trial text |
Biomarkers this organization publishes on (911)
Shown in this order: most publications first.
Showing 5 of 911 biomarkers.
On Scientist.com
YESHIVA UNIVERSITY is listed as a research supplier in the Scientist.com network.
Not on this page
Checked, with nothing recorded for this organization: related companies not grouped here, active development programs, approved assets, sec-reported annual financials, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, and workforce and board diversity, as filed.
Work with Montefiore Medical Center on Scientist.com
For prices, more details, or to contact Montefiore Medical Center, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.